From April 2026, insurers have introduced a new generation of Integrated Shield Plan (IP) riders following a Ministry of Health (MOH) requirement. The new riders no longer cover the minimum deductible, and the co-payment cap has been doubled, so headline rider premiums are lower — reportedly 16% to 84% cheaper than the previous versions, depending on insurer and tier.
The catch reported by The Business Times, citing analysis by insurance advisory firm Havend, is that five of seven insurers also raised the base IP premiums that sit underneath these riders — in one case by 76%. Because a policyholder pays for both the IP and the rider, the lifetime saving from switching is smaller than the rider-only headline suggests. Across the tables published in the article, the actual reduction in total lifetime premiums typically lands in the 11% to 29% range, with one Great Eastern configuration showing a 51% drop. On the largest policies the absolute saving can still exceed S$100,000 over a lifetime — but it is not the flat 30-plus percent some initial marketing implied.
At StickieMonies, we think this is a useful moment for clients to review — not rush. Whether it makes sense to switch depends on your age, health, likelihood of needing treatment in the near term, preferred ward class, and what you can comfortably keep paying as premiums rise with age. If you or your family are likely to require care soon, keeping an older rider with lower out-of-pocket exposure may still be worthwhile. If you are younger and healthy, the newer riders' lower premium may be a reasonable trade for a higher co-payment cap.
A few practical points worth knowing, hedged against the fact that specifics may change with MOH and insurer updates: policyholders who bought their rider before MOH's announcement on 27 November 2025 are not automatically moved to the new structure. Those who bought old riders on or after that date will be required to transition to a new rider at their next renewal from April 2028. The new co-payment cap is generally higher than the old S$3,000 panel cap, so a single serious hospitalisation could cost more out of pocket than under a legacy rider — please verify current figures with your insurer before deciding.
None of this is a call to buy or drop any specific product. IP riders vary meaningfully across insurers, and affordability is only one input. Health expectations (private hospital access, cancer drug cover, pre- and post-hospitalisation coverage), medical inflation, and your household's ability to absorb a larger co-payment in a bad year all matter. Insurance premiums are also not guaranteed and will typically continue to rise with age and medical cost inflation — a switch that looks affordable today may not feel that way in your seventies.
If you want a second pair of eyes on your existing IP and rider before you make a call, we're glad to walk through the numbers and trade-offs with you. The original Business Times report, including Havend's full comparison table across insurers, is linked below.